Lv32
242 积分 2024-04-12 加入
In Situ Tumor Surface Modification with Antibody Fragments for Antigen-Independent Versatile Cancer Immunotherapy
1天前
待确认
JSKN022, a first in class multi-specific ADC targeting PD-L1 and ITGB6/8 with an innovative DNA topoisomerase I inhibitor demonstrates encouraging efficacy in preclinical models
9天前
已关闭
Abstract 5450: JSKN022, a first in class multi-specific ADC targeting PD-L1 and ITGB6/8 with an innovative DNA topoisomerase I inhibitor demonstrates encouraging efficacy in preclinical models
9天前
已关闭
Exploring the role of ITGB6: fibrosis, cancer, and other diseases
9天前
已完结
Baicalein tethers CD274/PD-L1 for autophagic degradation to boost antitumor immunity
12天前
已完结
Enhancer-Associated LncRNA-ITGA2 Promotes Vascular Remodeling Through ITGA2
15天前
已完结
Silencing Myeloid Netrin-1 Induces Inflammation Resolution and Plaque Regression
15天前
已完结
Trans-resveratrol mitigates miR-204-3p mediated progression of allergic rhinitis by regulating the EGLN3/HIF-1α/IL33/ST2 signalling pathway
25天前
已完结
Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells
26天前
已关闭
Beyond detergent micelles: The advantages and applications of non-micellar and lipid-based membrane mimetics for solution-state NMR
27天前
已完结
皖公网安备34019202002308
